Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision
Authors
Keywords
Colon cancer, Stage II, Adjuvant therapy, 5-Fluorouracil, Formalin-fixed and paraffin-embedded tissues, Thymidylate synthase, MMR, CIMP
Journal
BMC GASTROENTEROLOGY
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-02-28
DOI
10.1186/1471-230x-13-36
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
- (2015) Oncotarget
- Colorectal cancer: a tale of two sides or a continuum?: Figure 1
- (2012) Mai Yamauchi et al. GUT
- Immunohistochemical Assessment of Lymphovascular Invasion in Stage I Colorectal Carcinoma
- (2011) Valeria Barresi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
- (2011) Robin K. Kelley et al. Clinical Colorectal Cancer
- Prognostic Significance of Lymphovascular Invasion in Sporadic Colorectal Cancer
- (2011) Seok-Byung Lim et al. DISEASES OF THE COLON & RECTUM
- Genome-scale analysis of aberrant DNA methylation in colorectal cancer
- (2011) T. Hinoue et al. GENOME RESEARCH
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
- (2011) Anna M Dahlin et al. MODERN PATHOLOGY
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
- (2010) A. Fariña-Sarasqueta et al. ANNALS OF ONCOLOGY
- The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
- (2010) A. M. Dahlin et al. CLINICAL CANCER RESEARCH
- 5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer
- (2010) Rodrigo Jover et al. GASTROENTEROLOGY
- Colorectal cancer molecular biology moves into clinical practice
- (2010) C. C. Pritchard et al. GUT
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability
- (2010) Marisa Donada et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
- (2010) Katsuhiko Nosho et al. JOURNAL OF PATHOLOGY
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups
- (2009) Inti Zlobec et al. CANCER
- Genetic Variants of Methyl Metabolizing Enzymes and Epigenetic Regulators: Associations with Promoter CpG Island Hypermethylation in Colorectal Cancer
- (2009) S. de Vogel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer
- (2009) Campbell S.D. Roxburgh et al. EUROPEAN JOURNAL OF CANCER
- Higher random oligo concentration improves reverse transcription yield of cDNA from bioptic tissues and quantitative RT-PCR reliability
- (2009) Ermanno Nardon et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
- (2009) Michael Stahl et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
- (2008) R. Soong et al. ANNALS OF ONCOLOGY
- Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
- (2008) L. Barault et al. CANCER RESEARCH
- Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
- (2008) William M. Grady et al. GASTROENTEROLOGY
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
- (2008) S. Ogino et al. GUT
- Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup?
- (2008) Barry Iacopetta et al. International Journal of Clinical Oncology
- The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile
- (2008) M Ferracin et al. JOURNAL OF PATHOLOGY
- Molecular Classification and Correlates in Colorectal Cancer
- (2007) Shuji Ogino et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started